(Q36336024)

English

Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

glomerulonephritis

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Melanie S Joy

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mary La

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jinzhao Wang

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Arlene S Bridges

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Yichun Hu

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Susan L Hogan

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Reginald F Frye

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Joyce Blaisdell

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Joyce A Goldstein

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mary Anne Dooley

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Kim L R Brouwer

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Ronald J Falk

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 September 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

74

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

445-455

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Metabolism and transport of oxazaphosphorines and the clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Clinical pharmacokinetics of cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Food-drug interactions via human cytochrome P450 3A (CYP3A).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Chemotherapy of small cell lung cancer: state of the art.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Combined modality treatments in early non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

An overview of cyclophosphamide development and clinical applications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Optimisation of cyclophosphamide therapy in systemic vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Prediction of creatinine clearance from serum creatinine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

30 September 2017

Cyclophosphamide metabolism in children with non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

29 June 2018

Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

29 June 2018

A phase I study of SR-2508 and cyclophosphamide administered by intravenous injection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

29 June 2018

Individual variation in the activation and inactivation of metabolic pathways of cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

29 June 2018

An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

22 September 2018

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

22 September 2018

Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

22 September 2018

Antimycotic drug discovery in the age of genomics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04223.X

21 January 2018

Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04223.X

21 January 2018

Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477346

5 December 2018

Steroid-resistant nephrotic syndrome: the influence of race on cyclophosphamide sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of cyclophosphamide (CP) and 4-OH-CP/aldophosphamide in systemic vasculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mafosfamide induces DNA fragmentation and apoptosis in human T-lymphocytes A possible mechanism of its immunosuppressive action

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography–mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS/MS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22380717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2012.04223.X

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36336024&oldid=1543914775"